Scholars Central

Research articlePublished 30 Sep 2022

Investigation of Vitamins as Potential Dual Inhibitors of Acetylcholinesterase and β-secretase

Authors: Haitham Ahmed Al-Madhagi

Department of Applied Sciences, University of Thamar, Thamar, Yemen

Journal of Alzheimers Disease & Parkinsonism

Volume 12 · Issue 5 · Pages 1–4

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Background: Alzheimer's Disease (AD) is a chronic neurodegenerative disease affecting primarily people with 65 years or older. The current therapy of AD involves the combination of at least 2 drug options to target different aspects of the disease. The study purpose is to investigate the capability of vitamins to act as dual inhibitors of acetylcholinesterase (AChE) as well as β-secretase (BACE) in silico. Methods: The whole set of vitamins structures were docked against AChE and BACE using the AutoDock vina interface within UCSF Chimera. In addition, ADME parameters were predicted via SwissADME server. Results: Two vitamins (vitamin K2 and B9) proved efficacious dual binding to both targets in comparison with the standard inhibitors of the examined targets. Nevertheless, their ADME properties were found to suffer from at least one violation to Lipinski's rule of five. Conclusion: Vitamins K2 and B9 are superior candidates as dual inhibitors for AD.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Alzheimers Disease & Parkinsonism
  • SubjectNeuroscience & Neurology
  • BylineArticles whose byline prints “Haitham Ahmed Al-Madhagi”